Rod MacKenzie, Pfizer chief development officer (Chris Ratcliffe/Bloomberg via Getty Images)
October 6, 2021 11:22 AM EDTUpdated 12:06 PM
People

Break­ing: Pfiz­er de­vel­op­ment chief Rod MacKen­zie is re­tir­ing af­ter a lengthy ca­reer capped by his­toric suc­cess

John Carroll

Editor & Founder

Pfiz­er’s clin­i­cal de­vel­op­ment chief and EVP Rod MacKen­zie is re­tir­ing from his post at the phar­ma gi­ant, right on the heels of a his­toric suc­cess …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bridge­Bio shares promis­ing re­sults in tri­al of Cana­van dis­ease gene ther­a­py

CRISPR ther­a­py re­duces swelling at­tacks by 81% in In­tel­lia fol­low-up study

Fac­ing lost re­bates, MGM Re­sorts to stop cov­er­ing GLP-1 weight loss shots

Ex­clu­sive: Uni­ver­si­ty of Toron­to spin­out rais­es $53.5M to cre­ate new obe­si­ty drugs with AI

Icon's quar­ter­ly earn­ings hit by biotech and phar­ma pull­back

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times